Electronic patient record since 2001. SDC Quality of Care Data 2009 – 2011 for Type 1 Diabetes NCQA indicatorGoal200920102011 HbA1c > 9,0 %≤ 15%20.822.220.8.

Slides:

Advertisements

Similar presentations

Building an Integrated System for Personalizing Care Tim Johnson, MD Spring, 2014.

Advertisements

National Diabetes Audit (NDA) PARTNERSHIP WORKING WITH PATIENTS AND SERVICE USERS Laura Fargher Diabetes UK.

Area 4 SHARP Face-to-Face Conference Phenotyping Team – Centerphase Project Assessing the Value of Phenotyping Algorithms June 30, 2011.

Lf/P.Richter,RN,Q.A.Dir. HEDIS 2011 Comprehensive Diabetic Care Rates Patricia Richter,RN, Director Quality Improvement lf /Patricia Richter,RN,Q.I.Dir.

Group exercise lecture 8. For the previous table What is the probability a patient with HIV has HBV infection (answer using probability notation)? What.

NATIONAL CLINICAL AUDIT A VOLUNTARY SECTOR PERSPECTIVE National Diabetes Audit (NDA) Laura Fargher Diabetes UK.

Introduction To The Alphabet Strategy And Evidence Based Medicine.

Al-Fada AA & Bin Abdulrahman KA, King Saud University, Riyadh, Saudi Arabia Assessment of Care for Type 2 Diabetic Patients at the PHC Clinics of a Referral.

Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.

Making Your Doctor Visit Count. Have a Medical Checkup Every 3–6 Months.

Trends in Health Care Disparities in Medicare Managed Care Sarah Hudson Scholle, MPH, DrPH AcademyHealth June 27, 2005.

Diabetes Recognition Program (DRP) June DRP Workshop June 2010 NCQA Overview NCQA Recognition Programs DRP Application & Survey Process Benefits.

Steven M. Wright, PhD Director of Epidemiology Office of Quality and Performance An Analysis of the Quality of Care Provided to Men and Women in the VA.

Quality improvement in non glycaemic targets in diabetic patients at Central Australian Aboriginal Congress John Boffa Public Health Medical Officer.

The Effect of Quality Improvement on Racial Disparities in Diabetes Care Thomas D. Sequist, MD MPH Alyce S. Adams, PhD Fang Zhang, MS Dennis Ross-Degnan,

Claims-Based Quality Measures CMS Physician Group Practice Demonstration Project Chealsea Nather 26 January 2005.

Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Pay for Performance: Choosing Measures Linda K. Shelton AVP, Product Development PFP Boot Camp for Physicians and Physician Organizations February 2006.

Designing a mobile health intervention for diabetes management in India Fiona Y. Akhtar MBA, MS | Mobile Health Design | June 10, 2013

Comprehensive Diabetes Care. Comprehensive Diabetes Care: HbA1c Testing (Commercial) Source: National Committee for Quality Assurance, The State of Health.

Identifying Elements JJ MR# 1234 Nov. 29, 2000 UAMS Endocrine Clinic Dr. Debra Simmons.

3 rd Annual Right Care Summit October 1 st, 2010 Stephen M. Shortell Ph.D., M.P.H. Dean, University of California, Berkeley, School of Public Health.

PICK A CARD When the picture you hold in your hand is displayed you will be asked a question Ready set go…….

Clinical and Economic Benefits Associated With the Achievement of Both HbA1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes Featured Article:

February 2013 Webinar: “Practical Ways to Help Get Our Diabetes Patients to Goal” Controlling the ABC’s Cases.

Use of EHR & Quality Based on Zhou, et al. The Relationship between Electronic Health Record Use and Quality of Care over Time. J Am Med Inform Assoc.

Following The DOH Directive Using Technology. 2 of 10 National Health Policy Directions Attain efficiency by using information technology (IT) in all.

Helping Medical Students Counsel Patients With Uncontrolled Type II Diabetes: An Innovative Approach Alice Fairman Daniels, MD,MS Assistant Professor Cook.

PICK A CARD The wheel will spin and whoever has that card will be asked a question about the subject pictured on the card Ready set go…….

COMPARING AUDIT DATA 2011 Program data Northeastern Tribal Health Systm *The clinical measures listed on these documents were used by the programs over.

Prevention of diabetes complications The alphabet strategy.

Redefining Quality Care in T2DM Patients with CV Disease

Diabetes Clinical Audit- July/Aug 2014

At the end of this talk, the resident will be able to:

Adding rosiglitazone to metformin in patients with type 2 diabetes: Effect on diabetes control and metabolic parameters Hussein Raef, Abdulraof Al-Mahfouz,

NDCCG National Diabetes Audit Results

Copyright © 2015 by the American Osteopathic Association.

Copyright © 2015 by the American Osteopathic Association.

(B.P :51) ( B:P52 ).

Potential effects of 10kg wt loss in Type 2 diabetes

Circ Cardiovasc Qual Outcomes

Systems, IT and Measurement: It’s All About Quality

Centricity Physician Office

Comparing Quality in Medicare FFS and Medicare Advantage

Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.

Figure 5 Risk factor control in the intensive treatment group

The risk of DR progression as related to mean HbA1c during DCCT

Level of risk factor control in the overall sample and by gender

Screening, enrollment, and randomization of study participants (BMI, body mass index; CTG, conventional therapy group; HbA1c, glycated hemoglobin; HDL-C,

Diabetes /care in Grampian

(A) Rate of achieving targets for glycated hemoglobin (HbA1c), blood pressure (BP), and lipids in all subjects and (B) prevalence of nephropathy, retinopathy,

Change in (A) total cholesterol; (B) LDL-cholesterol; (C) HDL-cholesterol and (D) triglycerides over 5 years in response to 12-week intensive lifestyle.

Association between antibiotic purchases and glycated hemoglobin (HbA1c) values in patients with and without diabetic nephropathy. Association between.

Chronic Disease Under Control: Managed Care Plan Distribution, 2006

CHRODIS PLUS Croatian pilot – Baseline analysis of indicators

Monitoring for diabetic complications in home care baseline data

Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary.

Change in markers of glycometabolism and cardiovascular risk profile.

Percentage of patients with type 2 diabetes with A1C < 7% (n = 248), blood pressure > 130/80 mmHg (n = 248), and LDL cholesterol < 100 mg/dl (n = 207)

The Burden of Diabetes.

Associations of body mass index (BMI) levels with achieving targets for glycated hemoglobin (HbA1c), blood pressure (BP), and lipids in the upper panels.

Percentage of patients with diabetes achieving HbA1c

ROC curves for cardiovascular events, all-cause mortality, and disease progression. ROC curves for cardiovascular events, all-cause mortality, and disease.

ROC curves for LDL cholesterol, apoB, non-HDL cholesterol, and the total cholesterol–to–HDL cholesterol ratio deciles. ROC curves for LDL cholesterol,

Patient disposition and study protocol.

Dr Naader Noory`s formulas about diabetes mellitus.

Mean BP by visit - all patients

Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.

Presentation transcript:

Electronic patient record since 2001

SDC Quality of Care Data 2009 – 2011 for Type 1 Diabetes NCQA indicatorGoal HbA1c > 9,0 %≤ 15% HbA1c < 7,0 %> 40% HbA1c < 8,0 %> 60% BP > 140/90≤ 35% BP < 130/80> 25% Eyes examined> 60% Non–smoker / advice> 80% LDL cholesterol > 3,3≤ 37% LDL cholesterol < 2,6> 36% Examination for nephropathy> 80% Feet examined> 80%

NCQA indicatorGoal HbA1c > 9,0 %≤ 15% HbA1c < 7,0 %> 40% HbA1c < 8,0 %> 60% BP > 140/90≤ 35% BP < 130/80> 25% Eyes examined> 60% Non–smoker / advice> 80% LDL cholesterol > 3,3≤ 37% LDL cholesterol < 2,6> 36% Examination for nephropathy> 80% Feet examined> 80% SDC Quality of Care Data 2009 – 2011 for Type 2 diabetes